In the vast starry sky of life science research, InnoModels Biotechnology (Beijing) Co., Ltd. lights a bright light for scientists with its leading ELISpot platform technology. As a high-tech enterprise co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion and Shanghai Jiao Tong University Institute of Immunology, InnoModels has not only made remarkable achievements in the field of oncology and tumor immunopharmacodynamics CRO services, translational medicine research services, and individualized healthcare, but also demonstrated extraordinary strengths and capabilities in the areas of immunology, biomedical research, and vaccine development with its ELISpot platform technology. The ELISpot platform technology has demonstrated its extraordinary strength and potential in immunology, biomedical research and vaccine development.
ELISpot platform: the perfect combination of high sensitivity and versatility
ELISpot technology is a highly sensitive method for the detection of substances secreted by individual cells. By optimizing this technology, InnoModels' ELISpot platform enables in-depth analysis of cellular responses and functions, especially in the study of immune cells, such as T cells and B cells, showing unique advantages. The platform not only quantitatively analyzes proteins produced by cells, such as cytokines and antibodies, but also accurately evaluates the function and activity of immune cells, which provides strong support for immune monitoring, vaccine development and cancer immunotherapy.
Customized solutions to meet diverse research needs
InnoModels Bio's ELISpot platform provides a variety of customized solutions to meet the needs of different fields and stages of research. The platform supports multiple CTL (cytotoxic T-lymphocyte) stimulation methods, including the use of human or mouse peripheral blood mononuclear cells (PBMCs) or spleen immune cells for in vitro specific antigen presentation. In addition, the platform enables analysis of CTL responses in peripheral blood or spleen cells after immunization in immunologically sound mice. This flexibility and customizability allows researchers to design the most appropriate experimental protocols based on specific research objectives.

High sensitivity and precise analysis for scientific breakthroughs
InnoModels' ELISpot platform is renowned for its excellent sensitivity and precision analysis capabilities. The platform is capable of detecting extremely low levels of CTL responses, ensuring that researchers can accurately measure and analyze CTL activity in different biological samples. This feature is particularly important in cancer vaccine research, as understanding and monitoring CTL responses is critical for assessing vaccine efficacy and optimizing treatment regimens. In addition, the platform provides the ability to quantitatively and qualitatively analyze the level of CTL production, enabling researchers to comprehensively assess the quantity and quality of CTL responses, providing strong support for scientific breakthroughs.
Wide range of application areas to advance life sciences
InnoModels' ELISpot platform has demonstrated extensive application value in various fields of life science research. In immunology research, the platform can be used to study the function and activity of immune cells and reveal the intrinsic mechanism of immune response; in biomedical research, the platform can be used to assess the impact of drugs on the immune system, providing an important basis for the development of new medicines; in vaccine development, the platform can be used to assess vaccine-induced immune response and optimize vaccine formulation and vaccination strategies. In addition, the platform can also be used in various fields such as research on infectious pathogens and autoimmune diseases, contributing to the overall progress of life science research.
Conclusion
InnoModels Biotechnology (Beijing) Co., Ltd. provides strong support for life science research with its leading ELISpot platform technology. With its high sensitivity, versatility and wide applicability, the platform plays an irreplaceable role in immunology, biomedical research and vaccine development. In the future, as the technology continues to advance and innovate, InnoModels' ELISpot platform will continue to provide scientists with more possibilities and promote the in-depth development of life science research.